Lung cancer
lung cancer, primary lung cancer
LUNG CANCER, CONTRALATERAL BREAST CANCER, EVENTS
In agreement with our previous report from this trialIncidence of primary lung cancer for patients randomized to two versus five years of tamoxifen.Incidence of lung cancer. Events after 2 versus 5 years of tamoxifen treatment. CI = confidence interval; HR = hazard ratio; SHR = subhazard ratio; TAM = tamoxifen.Before the randomization, 22 patients were diagnosed with contralateral breast cancer and 1 patient in each treatment group were diagnosed with lung cancer. These patients were excluded in this analysis.